Physician profile
Robert W Rowe
NPI 1033139134
$6,209.70
in general payments reported to CMS, 2019-2025
13 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.65 · 2021: $643 · 2022: $1,665 · 2023: $1,841 · 2024: $1,788 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,881.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $2,395.12 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $1,998.89 | 2021-2025 | |
| Janssen Biotech, INC. | $682.33 | 2021-2023 | Symtuza |
| Theratechnologies INC. | $525.34 | 2021-2024 | Trogarzo, Egrifta, Egrifta Sv |
| Merck Sharp & Dohme LLC | $347.01 | 2021-2025 | Pifeltro, Delstrigo |
| Janssen Pharmaceuticals, INC | $92.42 | 2021-2025 | Invega Sustenna |
| Hologic Sales and Service, LLC | $42.13 | 2023 | Thinprep 2000 Processor, Aptima |
| Stryker Corporation | $33.44 | 2025 | Pangea |
| Exact Sciences Corporation | $21.63 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $19.65 | 2019 | |
| Abbvie INC. | $18.05 | 2025 | |
| Emd Serono, INC. | $17.52 | 2021 | |
| Bausch Health US, LLC | $16.17 | 2025 | Aplenzin, Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.